Overall, AJ2 feeding or the combination of sNK cells and AJ2 restored IFN-γ secretion and effectively counteracted tumor-induced bone loss in this experimental model (Figure 2 and Figure 3B,C). The gene discussed is IFNG; the disease is neoplasm.